The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 4, 2011, Pages 844-851

  Alkhatatbeh, M J ^a,b   Mhaidat, N M ^c   Enjeti, A K ^b,d   Lincz, L F ^b,d   Thorne, R F ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^d CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

Author keywords

Atherosclerosis; Insulin resistance; Lipoproteins; Microparticles; Scavenger receptor; Soluble CD36

Indexed keywords

BIOLOGICAL MARKER; CD36 ANTIGEN; LIPOPROTEIN;

ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; CYTOMETRY; DENSITY GRADIENT CENTRIFUGATION; DIABETES MELLITUS; FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HYPOTHESIS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NORMAL HUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; ULTRACENTRIFUGATION;

ANTIGENS, CD36; BIOLOGICAL MARKERS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; PARTICLE SIZE; ULTRACENTRIFUGATION;

EID: 79953314261     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04220.x     Document Type: Article

References (34)

1. Okumura T, Jamieson GA. Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface. J Biol Chem 1976; 251: 5944-9.
2. Tandon NN, Lipsky RH, Burgess WH, Jamieson GA. Isolation and characterization of platelet glycoprotein IV (CD36). J Biol Chem 1989; 264: 7570-5.
3. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268: 11811-16.
4. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993; 268: 17665-8.
5. Febbraio M, Silverstein RL. CD36: implications in cardiovascular disease. Int J Biochem Cell Biol 2007; 39: 2012-30.
6. Greenwalt DE, Watt KW, So OY, Jiwani N. PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36 (GP IV). Biochemistry 1990; 29: 7054-9.
7. Gruarin P, De Monte L, Alessio M. CD36 folding revealed by conformational epitope expression is essential for cytoadherence of Plasmodium falciparum-infected red blood cells. Parasite Immunol 2000; 22: 349-60.
8. Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 1989; 58: 95-101.
9. Abumrad NA. CD36 may determine our desire for dietary fats. J Clin Invest 2005; 115: 2965-7.
10. Tao N, Wagner SJ, Lublin DM. CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. J Biol Chem 1996; 271: 22315-20.
11. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000; 6: 41-8.
12. Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA, Vega MA. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 1998; 39: 777-88.
13. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001; 108: 785-91.
14. Susztak K, Ciccone E, McCue P, Sharma K, Bottinger EP. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2005; 2: e45.
15. Handberg A, Levin K, Hojlund K, Beck-Nielsen H. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance. Circulation 2006; 114: 1169-76.
16. Handberg A, Norberg M, Stenlund H, Hallmans G, Attermann J, Eriksson JW. Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk. J Clin Endocrinol Metab 2010; 95: 1939-46.
17. Handberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sorensen K, Russell D, Dahl A, Ueland T, Oie E, Aukrust P, Halvorsen B. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability. Stroke 2008; 39: 3092-5.
18. Fernandez-Real JM, Handberg A, Ortega F, Hojlund K, Vendrell J, Ricart W. Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance. J Nutr Biochem 2009; 20: 477-84.
19. Jimenez-Dalmaroni MJ, Xiao N, Corper AL, Verdino P, Ainge GD, Larsen DS, Painter GF, Rudd PM, Dwek RA, Hoebe K, Beutler B, Wilson IA. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS ONE 2009; 4: e7411.
20. Wang L, Bao Y, Yang Y, Wu Y, Chen X, Si S, Hong B. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay. J Biomol Screen 2010; 15: 239-50.
21. Thorne RF, Zhang X, Song C, Jin B, Burns GF. Novel immunoblotting monoclonal antibodies against human and rat CD36/fat used to identify an isoform of CD36 in rat muscle. DNA Cell Biol 2006; 25: 302-11.
22. Jia W, Liu XS, Zhu Y, Li Q, Han WN, Zhang Y, Zhang JS, Yang K, Zhang XH, Jin BQ. Preparation and characterization of mabs against different epitopes of CD226 (PTA1). Hybridoma 2000; 19: 489-94.
23. Thorne RF, Meldrum CJ, Harris SJ, Dorahy DJ, Shafren DR, Berndt MC, Burns GF, Gibson PG. CD36 forms covalently associated dimers and multimers in platelets and transfected COS-7 cells. Biochem Biophys Res Commun 1997; 240: 812-18.
24. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J, Dignat-George F. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 2009; 7: 190-7.
25. Lacroix RPP, Robert S, Key NS, Dignat-George F. Standardization of flow cytometry-based enumeration of platelet microparticles using calibrated beads: results of instrument qualification. J Thromb Haemost 2009; 7(Suppl. 2): Abs. PP-WE-785.
26. Dean WL, Lee MJ, Cummins TD, Schultz DJ, Powell DW. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 2009; 102: 711-18.
27. Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995; 270: 16221-4.
28. Koga H, Sugiyama S, Kugiyama K, Fukushima H, Watanabe K, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J 2006; 27: 817-23.
29. Scherphof G, Roerdink F, Waite M, Parks J. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim Biophys Acta 1978; 542: 296-307.
30. Pearce SF, Wu J, Silverstein RL. A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain. Blood 1994; 84: 384-9.
31. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80: 1105-15.
32. Scott JL, Dunn SM, Jin B, Hillam AJ, Walton S, Berndt MC, Murray AW, Krissansen GW, Burns GF. Characterization of a novel membrane glycoprotein involved in platelet activation. J Biol Chem 1989; 264: 13475-82.
33. Ye X, Zhang Z, Jiang Y, Han X, Wang Y, Zhang M, Liu J, Geng W, Dai D, Shi W, Shang H. Expression of human CD226 on T cells and natural killer cells and of soluble CD226 in plasma of HIV-1-infected Chinese patients. Viral Immunol 2006; 19: 576-81.
34. The Soluble Insulin Receptor Study Group. Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes. Diabetes 2007; 56: 2028-35.